awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33431267-5E63979F-0566-4B69-99A6-56E50D862927
Q33431267-5E63979F-0566-4B69-99A6-56E50D862927
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33431267-5E63979F-0566-4B69-99A6-56E50D862927
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
P2860
Q33431267-5E63979F-0566-4B69-99A6-56E50D862927
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33431267-5E63979F-0566-4B69-99A6-56E50D862927
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67499a863de503e0e6a0c0f8ae6335183628c5af
P2860
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics.